Following demonstration that subjects could discern between placebo and oxycodone , @ eligible male and female subjects were randomized to receive intravenous injections of @ mg/kg oxycodone ( OXY ) , @ mg/kg oxycodone and @ mg/kg naloxone solution ( sOXN ) , or matching placebo over three visits .